243 related articles for article (PubMed ID: 34851157)
1. Dose Optimization of Combined Linezolid and Fosfomycin against
Mao J; Li T; Zhang N; Wang S; Li Y; Peng Y; Liu H; Yang G; Yan Y; Jiang L; Liu Y; Li J; Huang X
Microbiol Spectr; 2021 Dec; 9(3):e0087121. PubMed ID: 34851157
[TBL] [Abstract][Full Text] [Related]
2. Dose Optimization of Colistin Combinations against Carbapenem-Resistant Acinetobacter baumannii from Patients with Hospital-Acquired Pneumonia in China by Using an
Bian X; Liu X; Chen Y; Chen D; Li J; Zhang J
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745385
[TBL] [Abstract][Full Text] [Related]
3. In vitro activities of daptomycin combined with fosfomycin or rifampin on planktonic and adherent linezolid-resistant isolates of Enterococcus faecalis.
Zheng JX; Sun X; Lin ZW; Qi GB; Tu HP; Wu Y; Jiang SB; Chen Z; Deng QW; Qu D; Yu ZJ
J Med Microbiol; 2019 Mar; 68(3):493-502. PubMed ID: 30882300
[TBL] [Abstract][Full Text] [Related]
4. Developments in the pharmacokinetic/pharmacodynamic index of linezolid: a step toward dose optimization using Monte Carlo simulation in critically ill patients.
Dong H; Xie J; Chen L; Wang T; Sun J; Zhao Y; Dong Y
Int J Infect Dis; 2014 May; 22():35-40. PubMed ID: 24603161
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamics of Linezolid Plus Fosfomycin Against Vancomycin-Resistant
Wang S; Liu H; Mao J; Peng Y; Yan Y; Li Y; Zhang N; Jiang L; Liu Y; Li J; Huang X
Front Microbiol; 2021; 12():779885. PubMed ID: 34970238
[TBL] [Abstract][Full Text] [Related]
6. Synergistic properties of linezolid against Enterococcus spp. isolates: a systematic review from in vitro studies.
Antonello RM; Riccardi N; Saderi L; Sotgiu G
Eur J Clin Microbiol Infect Dis; 2024 Jan; 43(1):17-31. PubMed ID: 37975976
[TBL] [Abstract][Full Text] [Related]
7. Assessing the Emergence of Resistance in vitro and Invivo: Linezolid Combined with Fosfomycin Against Fosfomycin-Sensitive and Resistant
Li Y; Peng Y; Zhang N; Liu H; Mao J; Yan Y; Wang S; Yang G; Liu Y; Li J; Huang X
Infect Drug Resist; 2022; 15():4995-5010. PubMed ID: 36065277
[TBL] [Abstract][Full Text] [Related]
8. Treatment options for vancomycin-resistant enterococcal infections.
Linden PK
Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
[TBL] [Abstract][Full Text] [Related]
9. A study on combination of daptomycin with selected antimicrobial agents: in vitro synergistic effect of MIC value of 1 mg/L against MRSA strains.
Lee YC; Chen PY; Wang JT; Chang SC
BMC Pharmacol Toxicol; 2019 May; 20(1):25. PubMed ID: 31060599
[TBL] [Abstract][Full Text] [Related]
10. The combination of colistin and fosfomycin is synergistic against NDM-1-producing Enterobacteriaceae in in vitro pharmacokinetic/pharmacodynamic model experiments.
Albur MS; Noel A; Bowker K; MacGowan A
Int J Antimicrob Agents; 2015 Nov; 46(5):560-7. PubMed ID: 26387065
[TBL] [Abstract][Full Text] [Related]
11. In vitro efficacy of fosfomycin-based combinations against clinical vancomycin-resistant Enterococcus isolates.
Tang HJ; Chen CC; Zhang CC; Su BA; Li CM; Weng TC; Chiang SR; Ko WC; Chuang YC
Diagn Microbiol Infect Dis; 2013 Nov; 77(3):254-7. PubMed ID: 24029433
[TBL] [Abstract][Full Text] [Related]
12. Activities of fosfomycin and rifampin on planktonic and adherent Enterococcus faecalis strains in an experimental foreign-body infection model.
Oliva A; Furustrand Tafin U; Maiolo EM; Jeddari S; Bétrisey B; Trampuz A
Antimicrob Agents Chemother; 2014; 58(3):1284-93. PubMed ID: 24145537
[TBL] [Abstract][Full Text] [Related]
13. Oral Fosfomycin Treatment for Enterococcal Urinary Tract Infections in a Dynamic
Abbott IJ; van Gorp E; van der Meijden A; Wijma RA; Meletiadis J; Roberts JA; Mouton JW; Peleg AY
Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32253214
[TBL] [Abstract][Full Text] [Related]
14. Synergistic activity of fosfomycin and chloramphenicol against vancomycin-resistant Enterococcus faecium (VREfm) isolates from bloodstream infections.
Lagatolla C; Milic J; Imperi F; Cervoni M; Bressan R; Luzzati R; Di Bella S
Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115241. PubMed ID: 33130503
[TBL] [Abstract][Full Text] [Related]
15. Exploration of the Pharmacokinetic-Pharmacodynamic Relationships for Fosfomycin Efficacy Using an In Vitro Infection Model.
VanScoy BD; McCauley J; Ellis-Grosse EJ; Okusanya OO; Bhavnani SM; Forrest A; Ambrose PG
Antimicrob Agents Chemother; 2015 Dec; 59(12):7170-7. PubMed ID: 26100706
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic Attainment of the Synergism of Meropenem and Fosfomycin Combination against Pseudomonas aeruginosa Producing Metallo-β-Lactamase.
Albiero J; Mazucheli J; Barros JPDR; Szczerepa MMDA; Nishiyama SAB; Carrara-Marroni FE; Sy S; Fidler M; Sy SKB; Tognim MCB
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910903
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic/pharmacodynamic factors influencing emergence of resistance to linezolid in an in vitro model.
Boak LM; Li J; Rayner CR; Nation RL
Antimicrob Agents Chemother; 2007 Apr; 51(4):1287-92. PubMed ID: 17242144
[TBL] [Abstract][Full Text] [Related]
18. Elucidation of the pharmacokinetic/pharmacodynamic determinants of fosfomycin activity against Pseudomonas aeruginosa using a dynamic in vitro model.
Bilal H; Peleg AY; McIntosh MP; Styles IK; Hirsch EB; Landersdorfer CB; Bergen PJ
J Antimicrob Chemother; 2018 Jun; 73(6):1570-1578. PubMed ID: 29506207
[TBL] [Abstract][Full Text] [Related]
19. Concentration-dependent enrichment of resistant Enterococcus faecium exposed to linezolid in an in vitro dynamic model.
Alieva KN; Golikova MV; Portnoy YA; Dovzhenko SA; Kobrin MB; Zinner SH; Firsov AA
J Chemother; 2018; 30(6-8):364-370. PubMed ID: 30663551
[TBL] [Abstract][Full Text] [Related]
20. In Vitro and In Vivo Activities of a Bi-Aryl Oxazolidinone, RBx 11760, against Gram-Positive Bacteria.
Barman TK; Kumar M; Mathur T; Chaira T; Ramkumar G; Kalia V; Rao M; Pandya M; Yadav AS; Das B; Upadhyay DJ; Hamidullah ; Konwar R; Raj VS; Singh H
Antimicrob Agents Chemother; 2016 Dec; 60(12):7134-7145. PubMed ID: 27645240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
